<DOC>
	<DOC>NCT00997165</DOC>
	<brief_summary>The NUMEVOX cohort is intended to follow-up the macro and microvascular dysfunction in relation to adipose tissue repartition in patients with metabolic syndrome associated to liver steatosis, sleep apnea. Duration of the follow-up is 3 years for each patient entering the cohort.</brief_summary>
	<brief_title>Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>informed consent age &gt; 18 years old suspected of metabolic syndrome affiliated to french social health care age &lt; 18 years old pregnancy no informed consent not eligible for the study (no MS, cancer)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>fatty liver</keyword>
	<keyword>adipose tissue</keyword>
</DOC>